Case Report: Severe brigatinib-induced pneumonitis in a patient with EML4–ALK+ metastatic non-small cell lung adenocarcinoma

Anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs), such as brigatinib, are targeted therapies for metastatic non-small cell lung cancer (mNSCLC). We present a patient with echinoderm microtubule-associated protein-like 4 (EML4) and ALK fusion protein-positive mNSCLC who developed se...

Descripció completa

Dades bibliogràfiques

Autors principals:	Khyati Somayaji Dasika, Megan Melody, Jyoti D. Patel
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2025-04-01
Col·lecció:	Frontiers in Oncology
Matèries:	NSCLC pneumonitis tyrosine kinase inhibitor (TKI) steroids case report
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1572425/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!